Virtu Financial LLC Iterum Therapeutics PLC Transaction History

Virtu Financial LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$0.19 - $0.36 $32,750 - $62,053	-172,371 Reduced 60.94%	110,470 $22,000
Q1 2022 May 17, 2022	SELL	$0.31 - $0.45 $41,995 - $60,961	-135,469 Reduced 32.38%	282,841 $100,000
Q4 2021 Feb 17, 2022	BUY	$0.39 - $0.74 $163,140 - $309,549	418,310 New	418,310 $164,000
Q3 2021 Nov 12, 2021	SELL	$0.54 - $2.29 $45,175 - $191,576	-83,658 Closed	0 $0
Q2 2021 Sep 17, 2021	SELL	$0.97 - $2.39 $48,052 - $118,398	-49,539 Reduced 37.19%	83,658 $193,000
Q1 2021 May 19, 2021	BUY	$0.97 - $2.73 $87,383 - $245,934	90,086 Added 208.96%	133,197 $188,000
Q4 2020 Feb 24, 2021	BUY	$0.46 - $1.2 $19,831 - $51,733	43,111 New	43,111 $43,000
Q2 2020 Aug 07, 2020	SELL	$1.19 - $4.38 $26,645 - $98,072	-22,391 Closed	0 $0
Q4 2019 Feb 04, 2020	BUY	$1.7 - $5.99 $38,064 - $134,122	22,391 New	22,391 $101,000

145

Ticker ITRM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,233,400
Market Cap $21.2M
Description
Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, and the United States. It is developing sulopenem, a novel anti-infective compound with oral and IV formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract inf...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.